SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

$WAGMI is a community-driven meme token built on the Solana blockchain, designed to bring positivity, unity, and humor into the crypto space. The project encourages community engagement through memes, social interaction, and token-based activities. It leverages Solana’s fast and low-cost infrastructure to allow for smooth on-chain interactions, such as token transfers, community games, and NFT integration. The goal is to foster a fun, inclusive ecosystem where holders feel they are part of a larger movement – "We Are Gonna Make It."

WAGMI

WAGMI is gaining traction as community members rally around the project's potential and positive outlook, particularly within the Solana ecosystem. Discussions highlight the coin's strong community, locked liquidity, and long-term vision. The 

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is trending as the community discusses its potential for equity tokenization and real-world asset (RWA) integration, with JPM highlighted as a major financial firm utilizing the blockchain.  Community members are also weighing Solana against emerging infrastructure projects and meme coins on the network, expressing excitement for potential gains. The conversation also highlights the resilience of its ecosystem, specifically mentioning the WAGMI community.

Yee is a community based memecoin with one mission: to fight Pepe again. Made to honor the iconic meme rivalry we all know and love.  The Yee Legend  [Filed by: Yee’s Archivist & Legal Representative]  There’s something the meme world refuses to talk about: Pepe the Frog stole Yee the Dino’s entire launch plan.  Yee had been preparing for his comeback for months, but Pepe launched two weeks earlier, hijacking Yee’s concept and selling it as his own.  The charges? Meme theft, intellectual forgery, and historical erasure.  Yee’s official contract was filed in April 2023, right after Pepe’s surprise drop. This wasn’t timing—it was theft. The archives are about to open, and history is about to be corrected

Yee Token

$YEE is trending as a potential successor in the meme coin meta, drawing comparisons to $DOGE and $PEPE and generating excitement within its community. Discussions highlight its strong chart, potential for a breakout, and the narrative around its origins as part of a 'prophecy' alongside other successful meme coins. The community expresses strong conviction and anticipates significant growth, emphasizing its potential within the Ethereum ecosystem.

Pieverse

PIEVERSE is trending amid community discussion of potential short squeezes and liquidations, particularly in relation to Bitcoin's movements. Sentiment is further influenced by reports of scam concerns and observed trading bot activity, with some traders noting unusual volume and funding rate fluctuations.

Pump Mind Virus is a Pure Meme with a long term vision. We are building for the future while making no promises about the present. The project aims to bring the spirit of community memes back to the Solana ecosystem. We do that with engaging content and memes. Culture through community. Viral spread by word of mouth.  And most importantly, by not using the fake hype machine that has come to dominate the meme coin landscape.

PumpMindVirus

PumpMindVirus ($PMV) is trending due to its strong, meme-driven community and constant engagement, with members actively promoting its unique 'infected' culture within the Solana ecosystem. The community emphasizes the fun, energetic vibes, and continuous meme creation, even during market dips. $PMV is positioning itself as a leading meme coin with a focus on community and cultural spread.

Lantheus Holdings, Inc. engages in the provision of diagnostic imaging and nuclear medicine products. The firm develops products that help healthcare professionals in patient management and outcomes and assists clinicians with the detection of cardiovascular disease. It operates through the U.S. and International geographical segments. The U.S. segment produces and markets products, radiopharmacies, PMFs, integrated delivery networks, hospitals, clinics, and group practices throughout the United States. The International segment offers direct distribution in Canada and third-party distribution relationships in Europe, Canada, Australia, Asia-Pacific, Central America, and South America. The company was founded in 1956 and is headquartered in Bedford, MA.

Lantheus Holdings Inc

Lantheus Holdings is trending due to a recent analyst upgrade from Truist Securities and positive sentiment around the company's potential acquisition targets, particularly Radiopharm Theranostics (RADX). Community discussions highlight LNTH's bullish momentum, potential for a buyout, and the company's strategic positioning in the radiopharmaceutical space with upcoming catalysts.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta is trending as the community discusses its high throughput and compliance-first architecture, positioning it as a potential infrastructure layer for global finance. Community members highlight its capabilities in handling transactions and its integration with a major fiat anchor. This makes Keeta an infrastructure play that complements existing ecosystems.

BlackRock Institutional Trust Company N.A. - iShares MSCI India ETF

iShares MSCI India ETF

The iShares MSCI India ETF ($INDA) is trending due to a mix of factors, including large investments from companies like Microsoft, AI developments, and trade-related discussions between the U.S. and India. Community members are weighing potential tariff impacts and analyzing technical indicators, while some suggest India may be a more attractive investment relative to China.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending as the community discusses the potential impact of prediction markets and recent regulatory developments affecting competitors like Kalshi. Bullish sentiment is fueled by Missouri's sports betting launch, anticipation of the ESPN partnership, and overall positive outlooks for the sports betting sector. Some investors believe DraftKings is undervalued, expecting significant growth driven by upcoming sporting events and potential market share gains.

BlackRock Institutional Trust Company N.A. - iShares Russell 2000 ETF

iShares Russell 2000 ETF

IWM is trending due to discussions around rate cut expectations and potential impacts on small-cap companies, with some traders pointing to a rotation into small caps. Community members are actively debating potential breakout levels and whether the recent strength is sustainable, especially with upcoming economic data releases and Federal Reserve decisions on the horizon. There are also discussions around technical patterns and identifying key support and resistance levels for potential trades.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BVF Inc. IL Boosts Stake in Kymera Therapeutics, Inc. $KYMR

BVF Inc. IL raised its position in shares of Kymera Therapeutics, Inc. (NASDAQ:KYMR - Free Report) by 6.6% in the second quarter, according to the company in its most recent filing with the...

Kymera Therapeutics (NASDAQ:KYMR) Director Buys $172,499,918.00 in Stock

Kymera Therapeutics, Inc. (NASDAQ:KYMR - Get Free Report) Director Bros. Advisors Lp Baker acquired 2,005,813 shares of the business's stock in a transaction that occurred on Thursday, December 11th...

Kymera's Eczema Drug Gets Fast Track Designation in the United States

KYMR gains momentum as the FDA grants Fast Track to KT-621 for moderate to severe atopic dermatitis, boosting the stock and advancing its Type 2 pipeline.

Kymera Therapeutics (NASDAQ:KYMR) Director Bros. Advisors Lp Baker Acquires 2,005,813 Shares

Kymera Therapeutics, Inc. (NASDAQ:KYMR - Get Free Report) Director Bros. Advisors Lp Baker purchased 2,005,813 shares of the stock in a transaction dated Thursday, December 11th. The stock was...

Redmile Group LLC Trims Stock Holdings in Kymera Therapeutics, Inc. $KYMR

Redmile Group LLC cut its holdings in shares of Kymera Therapeutics, Inc. (NASDAQ:KYMR - Free Report) by 18.3% during the second quarter, according to the company in its most recent disclosure with...

Frontier Capital Management Co. LLC Grows Holdings in Kymera Therapeutics, Inc. $KYMR

Frontier Capital Management Co. LLC grew its stake in shares of Kymera Therapeutics, Inc. (NASDAQ:KYMR - Free Report) by 272.7% during the 2nd quarter, according to the company in its most recent 13F...

HC Wainwright Has Positive Estimate for KYMR FY2029 Earnings

Kymera Therapeutics, Inc. (NASDAQ:KYMR - Free Report) - HC Wainwright increased their FY2029 earnings estimates for shares of Kymera Therapeutics in a report released on Tuesday, December 9th. HC...

Norges Bank Invests $1.81 Million in Kymera Therapeutics, Inc. $KYMR

Norges Bank bought a new position in Kymera Therapeutics, Inc. (NASDAQ:KYMR - Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission...

Kymera Therapeutics (NASDAQ:KYMR) Price Target Raised to $125.00 at JPMorgan Chase & Co.

JPMorgan Chase & Co. boosted their price objective on shares of Kymera Therapeutics from $70.00 to $125.00 and gave the stock an "overweight" rating in a research report on Wednesday...

Kymera Therapeutics (NASDAQ:KYMR) Shares Gap Up After Analyst Upgrade

Kymera Therapeutics (NASDAQ:KYMR) Shares Gap Up on Analyst Upgrade...

Kymera Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and development of small molecule therapeutics that degrade disease-causing proteins. The company was founded by Bruce Lee Booth and Nello Mainolfi on September 29, 2015 and is headquartered in Watertown, MA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.80	--	--	N/A
Q3 '25	-$0.76	-$0.94	-23.44%	MISSED
Q2 '25	-$0.81	-$0.95	-17.28%	MISSED
Q1 '25	-$0.91	-$0.82	9.59%	BEAT
Q4 '24	-$0.70	-$0.88	-24.88%	MISSED

KYMR
Kymera Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest KYMR News

KYMRKymera Therapeutics Inc